11
TITLE: Mutant CFTR Drives TWIST1 mediated epithelial-mesenchymal transition
AUTHORS: Quaresma, MC ; Pankonien, I; Clarke, LA ; Sousa, LS; Silva, IAL; Railean, V; Dousova, T; Fuxe, J; Amaral, MD;
PUBLISHED: 2020, SOURCE: CELL DEATH & DISEASE, VOLUME: 11, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 32
12
TITLE: What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?
AUTHORS: Amaral, MD ; Quaresma, MC; Pankonien, I;
PUBLISHED: 2020, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 21, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 43
13
TITLE: CFTR modulator theratyping: Current status, gaps and future directions
AUTHORS: Clancy, JP; Cotton, CU; Donaldson, SH; Solomon, GM; VanDevanter, DR; Boyle, MP; Gentzsch, M; Nick, JA; Illek, B; Wallenburg, JC; Sorscher, EJ; Amaral, MD ; Beekman, JM; Naren, AP; Bridges, RJ; Thomas, PJ; Cutting, G; Rowe, S; Durmowicz, AG; Mense, M; Boeck, KD; Skach, W; Penland, C; Joseloff, E; Bihler, H; Mahoney, J; Borowitz, D; Tuggle, KL; ...More
PUBLISHED: 2019, SOURCE: JOURNAL OF CYSTIC FIBROSIS, VOLUME: 18, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 207
14
TITLE: Extent of rescue of F508de1-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients
AUTHORS: Kmit, A; Marson, FAL; Pereira, SVN; Vinagre, AM; Leite, GS; Servidoni, MF; Ribeiro, JD; Ribeiro, AF; Bertuzzo, CS; Amaral, MD ;
PUBLISHED: 2019, SOURCE: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, VOLUME: 1865, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 28
15
TITLE: Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic Reticulum
AUTHORS: Santos, JD; Canato, S; Carvalho, AS; Botelho, HM ; Aloria, K; Amaral, MD ; Matthiesen, R; Falcao, AO; Farinha, CM;
PUBLISHED: 2019, SOURCE: CELLS, VOLUME: 8, ISSUE: 4
INDEXED IN: WOS CrossRef: 23 Handle
16
TITLE: Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
AUTHORS: Nagy, B; Bene, Z; Fejes, Z; Heltshe, SL; Reid, D; Ronan, NJ; McCarthy, Y; Smith, D; Nagy, A; Joseloff, E; Balla, G; Kappelmayer, J; Macek, M; Bell, SC; Plant, BJ; Amaral, MD ; Balogh, I;
PUBLISHED: 2019, SOURCE: JOURNAL OF CYSTIC FIBROSIS, VOLUME: 18, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 19
17
TITLE: Increases in cytosolic Ca2+ induce dynamin- and calcineurin-dependent internalisation of CFTR
AUTHORS: Patel, W; Moore, PJ; Sassano, MF; Lopes Pacheco, M; Aleksandrov, AA; Amaral, MD ; Tarran, R; Gray, MA;
PUBLISHED: 2019, SOURCE: CELLULAR AND MOLECULAR LIFE SCIENCES, VOLUME: 76, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 12
18
TITLE: Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant
AUTHORS: Matos, AM; Pinto, FR ; Barros, P; Amaral, MD ; Pepperkok, R; Matos, P ;
PUBLISHED: 2019, SOURCE: JOURNAL OF BIOLOGICAL CHEMISTRY, VOLUME: 294, ISSUE: 36
INDEXED IN: Scopus WOS CrossRef: 15
19
TITLE: R560S: A class II CFTR mutation that is not rescued by current modulators  Full Text
AUTHORS: Awatade, NT; Ramalho, S; Silva, IAL; Felicio, V; Botelho, HM ; de Poel, E; Vonk, A; Beekman, JM; Farinha, CM; Amaral, MD ;
PUBLISHED: 2019, SOURCE: JOURNAL OF CYSTIC FIBROSIS, VOLUME: 18, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 25
20
TITLE: Speeding up access to new drugs for CF: Considerations for clinical trial design and delivery
AUTHORS: Davies, JC; Drevinek, P; Elborn, JS; Kerem, E; Lee, T; Amaral, MD ; de Boeck, K;
PUBLISHED: 2019, SOURCE: JOURNAL OF CYSTIC FIBROSIS, VOLUME: 18, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 17
Page 2 of 17. Total results: 169.